Gilead Sciences, Inc. 2024-10-09 Health critical FDA
Health · FDA · Recall #FDA-D-0005-2025
Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured… Recall
Issued October 9, 2024 · Gilead Sciences, Inc.
In October 2024, Gilead Sciences, Inc. recalled the Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured…, a critical health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Presence of Particulate Matter: Presence of glass particle.
What you should do
- 1 Stop using Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Gilead Sciences, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Gilead Sciences, Inc.
- Category
- Health
- Recall date
- October 9, 2024
- Units affected
- Not reported
- Sold at
- Nationwide in the U.S.A.
- Recall number
- FDA-D-0005-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- Gilead Sciences, Inc. has 1 recall in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.